Clinical Study of the Efficacy and Safety of BCD-263 and Opdivo® as Monotherapy in Subjects With Advanced Melanoma of the Skin
Clinical trial NCT06640530 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06640530
- Sponsor
- Biocad
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-21
- Primary completion
- 2025-12-01
- Enrollment
- 392
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.